MedTrace Logo

Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial

NCT04116125 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1380

Last updated 2019-10-04

No results posted yet for this study

Summary

The OBSERB study is a multi-center, non-blinded, pragmatic, parallel, randomized controlled trial in which patients with cT1-3N1 and ycN0 breast cancer.

Conditions

  • Breast Neoplasm Female
  • Lymphatic Metastasis

Interventions

PROCEDURE

Radiotherapy

Adjuvant radiotherapy on axillary region

Sponsors & Collaborators

  • Korean Breast Cancer Study Group

    collaborator OTHER

  • Kyungpook National University Chilgok Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2023-06-30
Completion
2025-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04116125 on ClinicalTrials.gov